Get the Stockscreener App
1.81
4.23%
-0.08
After Hours:
1.80
-0.01
-0.55%
Actinium Pharmaceuticals Inc Stock (ATNM) Forecast
The Actinium Pharmaceuticals Inc (ATNM) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $42.05, representing a +2,223% increase from the current price of $1.81. The highest analyst price target is $43.44, and the lowest is $40.66.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ATNM Price Target
Average 63.30
(+3,397% Upside)
Is Actinium Pharmaceuticals Inc (ATNM) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 72.23 | Sell |
| STOCH(9,6) | 63.44 | Neutral |
| STOCHRSI(14) | 79.46 | Neutral |
| MACD(12,26) | 0.1581 | Buy |
| ADX(14) | 34.41 | Buy |
| William %R | -45.45 | Neutral |
| CCI(14) | 115.98 | Buy |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.53
Buy
|
1.5896
Buy
|
| MA20 |
1.337
Buy
|
1.4357
Buy
|
| MA50 |
1.2548
Buy
|
1.3357
Buy
|
| MA100 |
1.3342
Buy
|
1.5894
Buy
|
| MA200 |
2.6302
Sell
|
2.6172
Sell
|
Buy: 8
Sell: 2
Neutral: 0
Summary: Buy
According to our latest analysis, ATNM could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 3 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on ATNM, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 72.23 indicates that ATNM is overbought. This suggests that ATNM price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 63.44 indicates that ATNM is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 79.46 indicates that ATNM is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 34.41 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 115.98 indicates that ATNM is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term ATNM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Actinium Pharmaceuticals Inc financial reports and earnings history, Actinium Pharmaceuticals Inc (ATNM) stock could reach $22.30 by 2030, $519.46 by 2040 and $624.24 by 2050. See the projected annual prices until 2050 of the Actinium Pharmaceuticals Inc stock below:
- Actinium Pharmaceuticals Inc (ATNM) is expected to reach an average price of $392.13 in 2035, with a high prediction of $392.38 and a low estimate of $387.40. This indicates an $21,565% rise from the last recorded price of $1.81.
- Actinium Pharmaceuticals Inc (ATNM) stock is projected to chart a bullish course in 2040, with an average price target of $518.86, representing an $28,566% surge from its current level. The forecast ranges from a conservative $512.32 to a sky-high $519.46.
- Our analysts predict Actinium Pharmaceuticals Inc (ATNM) to jump 32,790% by 2045, soaring from $586.72 to an average price of $595.31, potentially reaching $595.71. While $586.72 is the low estimate, the potential upside is significant.
- Actinium Pharmaceuticals Inc (ATNM) stock is expected to climb by 2050, reaching an average of $624.03, a $34,377% jump from its current level. However, a wide range of estimates exists, with high and low targets of $624.24 and $613.43, respectively, highlighting the market's uncertainty.
Actinium Pharmaceuticals Inc Stock (ATNM) Year by Year Forecast
Actinium Pharmaceuticals Inc Stock (ATNM) Price Forecast for 2025
Actinium Pharmaceuticals Inc Stock (ATNM) is expected to reach an average price of $55.47 in 2025, with a high prediction of $79.41 and a low estimate of $31.52. This indicates an +2,965% rise from the last recorded price of $1.81.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2025 | $43.43 | $40.66 | $43.44 | +2,299% |
| May, 2025 | $46.28 | $44.11 | $46.29 | +2,457% |
| June, 2025 | $49.01 | $46.91 | $49.03 | +2,608% |
| July, 2025 | $52.72 | $49.71 | $52.79 | +2,812% |
| August, 2025 | $55.51 | $53.39 | $55.54 | +2,967% |
| September, 2025 | $58.37 | $56.17 | $58.55 | +3,125% |
| October, 2025 | $68.77 | $59.02 | $70.58 | +3,700% |
| November, 2025 | $73.94 | $69.04 | $74.24 | +3,985% |
| December, 2025 | $77.70 | $73.95 | $79.41 | +4,193% |
Actinium Pharmaceuticals Inc Stock (ATNM) Price Forecast for 2026
The predicted value for Actinium Pharmaceuticals Inc (ATNM) in 2026 is set at an average of $96.29. Estimates vary from a peak of $114.42 to a trough of $78.16, indicating an +5,220% surge from the present price of $1.81.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $81.74 | $78.16 | $83.03 | +4,416% |
| February, 2026 | $84.69 | $81.83 | $85.25 | +4,579% |
| March, 2026 | $84.47 | $82.46 | $85.94 | +4,567% |
| April, 2026 | $88.48 | $84.93 | $89.26 | +4,788% |
| May, 2026 | $91.30 | $87.97 | $91.94 | +4,944% |
| June, 2026 | $93.39 | $91.22 | $93.65 | +5,060% |
| July, 2026 | $95.85 | $93.33 | $96.16 | +5,196% |
| August, 2026 | $100.07 | $96.55 | $100.29 | +5,429% |
| September, 2026 | $102.33 | $100.29 | $102.73 | +5,553% |
| October, 2026 | $104.74 | $102.39 | $104.87 | +5,687% |
| November, 2026 | $106.75 | $104.83 | $106.91 | +5,798% |
| December, 2026 | $113.04 | $107.40 | $114.42 | +6,146% |
Actinium Pharmaceuticals Inc Stock (ATNM) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Actinium Pharmaceuticals Inc (ATNM) is $129.80, with a high forecast of $146.51 and a low forecast of $113.09. This indicates an +7,071% increase from the last price of $1.81.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $115.30 | $113.09 | $115.33 | +6,270% |
| February, 2027 | $117.40 | $115.21 | $118.03 | +6,386% |
| March, 2027 | $120.28 | $117.53 | $120.66 | +6,545% |
| April, 2027 | $121.89 | $120.22 | $122.23 | +6,634% |
| May, 2027 | $124.04 | $121.99 | $124.51 | +6,753% |
| June, 2027 | $127.36 | $124.54 | $127.88 | +6,936% |
| July, 2027 | $130.30 | $127.81 | $130.56 | +7,099% |
| August, 2027 | $134.85 | $130.91 | $135.46 | +7,350% |
| September, 2027 | $137.12 | $134.30 | $137.60 | +7,476% |
| October, 2027 | $139.45 | $137.59 | $139.69 | +7,605% |
| November, 2027 | $142.32 | $140.09 | $142.35 | +7,763% |
| December, 2027 | $146.51 | $142.72 | $146.51 | +7,994% |
Actinium Pharmaceuticals Inc Stock (ATNM) Price Forecast for 2028
In 2028, Actinium Pharmaceuticals Inc (ATNM) is projected to reach an average price of $165.87, with a high projection of $184.74 and a low estimate of $147.00. This indicates an +9,064% rise from the last price of $1.81.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $151.36 | $147.00 | $151.52 | +8,262% |
| February, 2028 | $153.58 | $151.25 | $153.90 | +8,385% |
| March, 2028 | $163.25 | $153.68 | $163.60 | +8,919% |
| April, 2028 | $163.51 | $160.93 | $165.53 | +8,934% |
| May, 2028 | $166.05 | $163.71 | $167.06 | +9,074% |
| June, 2028 | $169.81 | $166.18 | $169.91 | +9,282% |
| July, 2028 | $174.61 | $170.20 | $174.61 | +9,547% |
| August, 2028 | $173.63 | $171.65 | $177.71 | +9,493% |
| September, 2028 | $176.90 | $174.32 | $177.39 | +9,673% |
| October, 2028 | $179.52 | $177.34 | $179.92 | +9,818% |
| November, 2028 | $182.61 | $179.59 | $182.77 | +9,989% |
| December, 2028 | $184.44 | $182.99 | $184.74 | +10,090% |
Actinium Pharmaceuticals Inc Stock (ATNM) Price Forecast for 2029
The 2029 price forecast for Actinium Pharmaceuticals Inc Stock (ATNM) is $117.99 on average, with a high prediction of $220.71 and a low estimate of $15.28. This represents an +6,419% increase from the previous price of $1.81.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $187.65 | $184.78 | $187.68 | +10,267% |
| February, 2029 | $189.35 | $188.01 | $189.51 | +10,361% |
| March, 2029 | $192.71 | $190.03 | $193.82 | +10,547% |
| April, 2029 | $194.86 | $192.86 | $195.07 | +10,666% |
| May, 2029 | $196.84 | $195.29 | $197.43 | +10,775% |
| June, 2029 | $200.28 | $197.44 | $200.29 | +10,965% |
| July, 2029 | $203.12 | $200.97 | $204.24 | +11,122% |
| August, 2029 | $206.92 | $203.71 | $207.63 | +11,332% |
| September, 2029 | $211.20 | $207.53 | $211.51 | +11,569% |
| October, 2029 | $217.05 | $212.00 | $217.71 | +11,891% |
| November, 2029 | $217.50 | $216.27 | $219.75 | +11,916% |
| December, 2029 | $15.29 | $15.28 | $220.71 | +744.55% |
Actinium Pharmaceuticals Inc Stock (ATNM) Price Forecast for 2030
Actinium Pharmaceuticals Inc Stock (ATNM) is expected to reach an average price of $52.36 in 2030, with a high forecast of $88.06 and a low forecast of $16.67. This signifies an +2,793% surge from the last price of $1.81.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $22.26 | $16.67 | $22.30 | +1,130% |
| February, 2030 | $27.86 | $23.65 | $27.89 | +1,439% |
| March, 2030 | $33.47 | $29.25 | $33.48 | +1,749% |
| April, 2030 | $39.05 | $34.83 | $39.08 | +2,058% |
| May, 2030 | $46.05 | $40.44 | $46.07 | +2,444% |
| June, 2030 | $51.79 | $47.45 | $51.85 | +2,761% |
| July, 2030 | $58.66 | $53.06 | $58.68 | +3,141% |
| August, 2030 | $64.25 | $60.05 | $64.27 | +3,450% |
| September, 2030 | $69.90 | $65.65 | $69.91 | +3,762% |
| October, 2030 | $76.91 | $71.30 | $76.92 | +4,149% |
| November, 2030 | $82.47 | $78.29 | $82.54 | +4,456% |
| December, 2030 | $88.04 | $83.83 | $88.06 | +4,764% |
0.39%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):